| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| HumanPheno | Self-injurious behavior | DMXL2 TRIO TSC1 KMT2E SLITRK1 CASZ1 CDKL5 ASXL3 TRIM8 FOXP1 HERC2 RAI1 | 2.42e-06 | 210 | 57 | 12 | HP:0100716 |
| Domain | Quinoprotein_ADH-like_supfam | 5.24e-05 | 53 | 143 | 5 | IPR011047 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | TRIO DOCK9 SLITRK3 PRAG1 PLEKHG4B DST FAM13A BAIAP2L1 ITSN2 AKAP13 ARHGAP27 PEAK1 PHIP | 1.22e-05 | 450 | 97 | 13 | M27078 |
| Pathway | REACTOME_HEME_SIGNALING | 2.09e-05 | 49 | 97 | 5 | M41832 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | TRIO DOCK9 SLITRK3 PRAG1 DST FAM13A BAIAP2L1 ITSN2 AKAP13 ARHGAP27 PEAK1 PHIP | 4.65e-05 | 439 | 97 | 12 | MM15595 |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.18e-04 | 70 | 97 | 5 | M938 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.39e-04 | 18 | 97 | 3 | M26942 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 2.95e-04 | 85 | 97 | 5 | MM14746 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 3.31e-04 | 20 | 97 | 3 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 3.31e-04 | 20 | 97 | 3 | MM14991 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | TRIO DOCK9 SLITRK3 PRAG1 ITGB3BP PLEKHG4B DST FAM13A BAIAP2L1 ITSN2 AKAP13 ARHGAP27 PEAK1 PHIP | 3.94e-04 | 720 | 97 | 14 | M41838 |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 4.62e-04 | 5 | 97 | 2 | M49002 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | TRIO DOCK9 SLITRK3 PRAG1 ITGB3BP DST FAM13A BAIAP2L1 ITSN2 AKAP13 ARHGAP27 PEAK1 PHIP | 4.89e-04 | 649 | 97 | 13 | MM15690 |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 5.44e-04 | 97 | 97 | 5 | M9400 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 5.49e-04 | 55 | 97 | 4 | M27145 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO3 MAGI1 NCOA6 CRTC3 SHROOM3 RAP1GAP GBF1 RAPH1 TRIO TRPM7 RICTOR PRAG1 CDCA2 DST FAM13A BAIAP2L1 TET1 NAV2 AKAP13 MPHOSPH9 SSH2 CRYBG3 PEAK1 CNOT4 | 3.09e-13 | 861 | 148 | 24 | 36931259 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FOXO3 PITPNM2 SLC12A6 MAGI1 INTU SHROOM3 TRIO PPFIA2 SLITRK3 NSRP1 CASZ1 HNRNPF LRCH3 PLEKHG4B YEATS2 EPS15L1 PTPRB FAM13A ATXN7 EEPD1 AFF1 FOXP1 AKAP13 RPRD2 HPS5 VPS13B AFF4 RAI1 PDZD2 | 5.98e-12 | 1489 | 148 | 29 | 28611215 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 CRTC3 SHROOM3 CCPG1 GBF1 MLLT10 KMT2E ADNP PLEKHG4B BAIAP2L1 UBQLN3 AFF1 HSH2D AKAP13 | 5.17e-09 | 430 | 148 | 14 | 35044719 |
| Pubmed | USP36 PITPNM2 CASP8AP2 NCOA6 SHROOM3 ABCA2 ADNP TRANK1 DST TET1 NAV2 PCNX1 RPRD2 HPS5 RAI1 | 9.13e-09 | 529 | 148 | 15 | 14621295 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FOXO3 PITPNM2 NCOA6 SHROOM3 ABCA2 GBF1 TRIO DOCK9 IRAK1 MLLT10 PRAG1 CASZ1 FAM20C EPS15L1 FAT1 DST NAV2 PCNX1 AKAP13 HERC2 RAI1 | 1.05e-08 | 1105 | 148 | 21 | 35748872 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MAGI1 COL16A1 TRPM7 DOCK9 RICTOR TSC1 SLITRK3 ATP10D CDKL5 FAT1 BAIAP2L1 LNPEP NAV2 PEAK1 VPS13B | 2.39e-08 | 569 | 148 | 15 | 30639242 |
| Pubmed | 4.92e-08 | 225 | 148 | 10 | 12168954 | ||
| Pubmed | 6.87e-08 | 125 | 148 | 8 | 29467281 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | USP36 NCOA6 BRIP1 MED1 ADNP NSRP1 HNRNPF STAU1 CDCA2 YEATS2 EPS15L1 ZZZ3 ZNF644 RPRD2 PRRC2A PHIP AFF4 RAI1 | 1.43e-07 | 954 | 148 | 18 | 36373674 |
| Pubmed | INTU DOCK9 PPM1E TSC1 YEATS2 FCHSD2 ZNF644 ITSN2 RIMBP2 VPS13B PLCE1 PDZD2 | 1.96e-07 | 407 | 148 | 12 | 12693553 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.30e-07 | 202 | 148 | 9 | 33005030 | |
| Pubmed | CASP8AP2 RAPH1 IRAK1 ADNP PALB2 YEATS2 ZZZ3 DST ZNF644 TET1 FOXP1 CRYBG3 | 2.60e-07 | 418 | 148 | 12 | 34709266 | |
| Pubmed | 5.09e-07 | 222 | 148 | 9 | 37071664 | ||
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 5.14e-07 | 111 | 148 | 7 | 22558309 | |
| Pubmed | USP36 RAPH1 TRIO PPM1E RICTOR TSC1 EYA2 CDCA2 PTPRB LNPEP MPHOSPH9 SSH2 CRYBG3 PEAK1 HERC2 CDC25A YME1L1 PRRC2A | 5.71e-07 | 1049 | 148 | 18 | 27880917 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA6 BRIP1 GBF1 RAPH1 RICTOR MED1 PALB2 HNRNPF YEATS2 EPS15L1 FAM13A ATXN7 ZNF644 AFF1 PRRC2A | 1.21e-06 | 774 | 148 | 15 | 15302935 |
| Pubmed | HDAC9 DMXL2 RAP1GAP GBF1 ZNF407 RICTOR SLITRK1 CASZ1 EEPD1 SSH2 PEAK1 PLEKHH2 | 1.47e-06 | 493 | 148 | 12 | 15368895 | |
| Pubmed | MAGI1 DMXL2 CCPG1 GBF1 COL16A1 TRIO OMG EPS15L1 FAT1 AKAP13 RPRD2 SSH2 PLEKHH2 FOXF1 | 1.61e-06 | 689 | 148 | 14 | 36543142 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | FOXO3 GBF1 EML6 IRAK1 MUC16 SLITRK3 EYA2 ZZZ3 PTPRB PCNX1 HERC2 | 2.03e-06 | 420 | 148 | 11 | 28065597 |
| Pubmed | MAGI1 GLRX3 IRAK1 RICTOR HNRNPF STAU1 EPS15L1 DST BAIAP2L1 ZC3HAV1L MPHOSPH9 CRYBG3 PEAK1 PRRC2A | 2.21e-06 | 708 | 148 | 14 | 39231216 | |
| Pubmed | 2.42e-06 | 268 | 148 | 9 | 33640491 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 17962186 | ||
| Pubmed | The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin. | 2.61e-06 | 7 | 148 | 3 | 15856011 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | FOXO3 SHROOM3 RAPH1 TRIO IRAK1 TSC1 MTPAP CEP164 EPS15L1 BAIAP2L1 MEIOC ITSN2 MPHOSPH9 HERC2 CNOT4 | 3.95e-06 | 853 | 148 | 15 | 28718761 |
| Pubmed | NCOA6 differentially regulates the expression of the CYP2C9 and CYP3A4 genes. | 4.16e-06 | 8 | 148 | 3 | 21292004 | |
| Pubmed | NCOA6 RAPH1 IRAK1 MED1 ADNP YEATS2 EPS15L1 ZZZ3 TET1 RPRD2 PEAK1 PRRC2A | 4.44e-06 | 549 | 148 | 12 | 38280479 | |
| Pubmed | 5.16e-06 | 102 | 148 | 6 | 11214970 | ||
| Pubmed | 5.46e-06 | 103 | 148 | 6 | 10574462 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 5.77e-06 | 104 | 148 | 6 | 31240132 | |
| Pubmed | USP36 INTU IRAK1 RICTOR MTPAP NSRP1 YEATS2 FAT1 ZZZ3 ATXN7 FOXP1 BICRAL CRYBG3 YME1L1 PHIP AFF4 RAI1 | 5.89e-06 | 1116 | 148 | 17 | 31753913 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MAGI1 SHROOM3 RAPH1 DOCK9 IRAK1 CDKL5 EPS15L1 DST BAIAP2L1 NAV2 CRYBG1 PEAK1 | 5.93e-06 | 565 | 148 | 12 | 25468996 |
| Pubmed | USP36 NCOA6 BRIP1 RAPH1 TRIO MED1 YEATS2 DST BAIAP2L1 RPRD2 CRYBG3 | 6.18e-06 | 472 | 148 | 11 | 38943005 | |
| Pubmed | HDAC9 MAGI1 CASP8AP2 CRTC3 DST ITSN2 NAV2 AKAP13 BICRAL MPHOSPH9 HERC2 | 8.12e-06 | 486 | 148 | 11 | 20936779 | |
| Pubmed | PITPNM2 SLC12A6 DMXL2 RAP1GAP TRIO PPFIA2 TSC1 OMG HNRNPF LRCH3 STAU1 CDKL5 EPS15L1 DST ITSN2 RIMBP2 SSH2 PEAK1 PRRC2A | 1.14e-05 | 1431 | 148 | 19 | 37142655 | |
| Pubmed | SLC12A6 DMXL2 GBF1 TRPM7 TSC1 RRAGC LRCH3 DST LNPEP YME1L1 VPS13B | 1.14e-05 | 504 | 148 | 11 | 34432599 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | USP36 RAPH1 IRAK1 TSC1 MED1 ADNP NSRP1 HNRNPF STAU1 YEATS2 EPS15L1 DST RPRD2 PRRC2A AFF4 | 1.16e-05 | 934 | 148 | 15 | 33916271 |
| Pubmed | 1.22e-05 | 11 | 148 | 3 | 12446761 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 12189208 | ||
| Pubmed | Phospholipase Cε Modulates Rap1 Activity and the Endothelial Barrier. | 1.80e-05 | 2 | 148 | 2 | 27612188 | |
| Pubmed | Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families. | 1.80e-05 | 2 | 148 | 2 | 22692731 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 28466777 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 36227108 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 37528066 | ||
| Pubmed | FOXO3a regulates glycolysis via transcriptional control of tumor suppressor TSC1. | 1.80e-05 | 2 | 148 | 2 | 20371605 | |
| Pubmed | Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases. | 1.80e-05 | 2 | 148 | 2 | 27531744 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24843025 | ||
| Pubmed | PLAU inferred from a correlation network is critical for suppressor function of regulatory T cells. | 1.80e-05 | 2 | 148 | 2 | 23169000 | |
| Pubmed | Rictor/mTORC2 is involved in endometrial receptivity by regulating epithelial remodeling. | 1.80e-05 | 2 | 148 | 2 | 34131963 | |
| Pubmed | Structure of SgK223 pseudokinase reveals novel mechanisms of homotypic and heterotypic association. | 1.80e-05 | 2 | 148 | 2 | 29079850 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 29666340 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 20605949 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 25201756 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 16135805 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 29277934 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 26007649 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23079602 | ||
| Pubmed | Depletion of mTOR ameliorates CD4+ T cell pyroptosis by promoting autophagy activity in septic mice. | 1.80e-05 | 2 | 148 | 2 | 37738689 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 16828057 | ||
| Pubmed | NCOA6 MUC16 MED1 CASZ1 YEATS2 ATXN7 ASXL3 ITSN2 TRIM8 NCOA1 YME1L1 RAI1 | 1.98e-05 | 638 | 148 | 12 | 31182584 | |
| Pubmed | USP36 SHROOM3 PCDHB7 RICTOR MED1 MTPAP CASZ1 CEP164 LRCH3 SPATS2L DST ATXN7 LNPEP ITSN2 CRYBG1 HERC2 YME1L1 PRRC2A AFF4 | 2.12e-05 | 1497 | 148 | 19 | 31527615 | |
| Pubmed | 2.14e-05 | 78 | 148 | 5 | 28611094 | ||
| Pubmed | TRAF3IP2 DMXL2 RAP1GAP RICTOR NCAPG2 HNRNPF DST AKAP13 CRYBG3 HPS5 CNOT4 PLCE1 | 2.38e-05 | 650 | 148 | 12 | 38777146 | |
| Pubmed | Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha. | 2.66e-05 | 14 | 148 | 3 | 12039952 | |
| Pubmed | 2.66e-05 | 14 | 148 | 3 | 20854876 | ||
| Pubmed | USP36 SHROOM3 TRPM7 MUC16 RICTOR CDCA2 CDKL5 EPS15L1 FAT1 DST BAIAP2L1 MPHOSPH9 PEAK1 | 3.01e-05 | 777 | 148 | 13 | 35844135 | |
| Pubmed | NCOA6 IRAK1 MLLT10 ADNP STAU1 CDCA2 YEATS2 FAT1 ZZZ3 DST ATXN7 RFXANK ZNF644 NCOA1 FOXP1 RPRD2 HERC2 PRRC2A | 3.93e-05 | 1429 | 148 | 18 | 35140242 | |
| Pubmed | MAGI1 RAPH1 TRIO DOCK9 NSRP1 LRCH3 PLEKHG4B EPS15L1 FAM13A ITSN2 AKAP13 PEAK1 YME1L1 PRRC2A | 3.95e-05 | 916 | 148 | 14 | 32203420 | |
| Pubmed | 4.81e-05 | 151 | 148 | 6 | 17043677 | ||
| Pubmed | Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity. | 5.38e-05 | 3 | 148 | 2 | 21273440 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 27163153 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 16914740 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 23475984 | ||
| Pubmed | Carom: a novel membrane-associated guanylate kinase-interacting protein with two SH3 domains. | 5.38e-05 | 3 | 148 | 2 | 14627983 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 17045797 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 19439667 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 21765414 | ||
| Pubmed | Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. | 5.38e-05 | 3 | 148 | 2 | 20133621 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 12403843 | ||
| Pubmed | Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. | 5.38e-05 | 3 | 148 | 2 | 24014651 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 19706513 | ||
| Pubmed | Steroid receptor induction of gene transcription: a two-step model. | 5.38e-05 | 3 | 148 | 2 | 9223281 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 29232555 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 31668132 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 28796317 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 19504183 | ||
| Pubmed | mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors. | 5.38e-05 | 3 | 148 | 2 | 26833095 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 18239069 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 32558878 | ||
| Pubmed | The vitamin D receptor interacts preferentially with DRIP205-like LxxLL motifs. | 5.38e-05 | 3 | 148 | 2 | 17254542 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 33097673 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 21409391 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 24190884 | ||
| Pubmed | JAB1 interacts with both the progesterone receptor and SRC-1. | 5.38e-05 | 3 | 148 | 2 | 10722692 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 9708794 | ||
| Pubmed | Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort. | 5.38e-05 | 3 | 148 | 2 | 19763819 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 22331472 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 26383589 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 12556966 | ||
| Pubmed | Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1. | 5.38e-05 | 3 | 148 | 2 | 12529333 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 10588740 | ||
| Interaction | YWHAH interactions | FOXO3 MAGI1 NCOA6 CRTC3 SHROOM3 ABCA2 RAP1GAP GBF1 TRIO TRPM7 DOCK9 RICTOR TSC1 MED1 PRAG1 CDCA2 DST FAM13A BAIAP2L1 TET1 NAV2 NCOA1 AKAP13 MPHOSPH9 SSH2 CRYBG3 PEAK1 CDC25A CNOT4 | 1.03e-09 | 1102 | 145 | 29 | int:YWHAH |
| Interaction | SFN interactions | FOXO3 HDAC9 MAGI1 NCOA6 CRTC3 SHROOM3 RAP1GAP GBF1 TRPM7 RICTOR RRAGC DST FAM13A NAV2 AKAP13 MPHOSPH9 SSH2 CRYBG3 PEAK1 CDC25A | 1.24e-07 | 692 | 145 | 20 | int:SFN |
| Interaction | YWHAZ interactions | FOXO3 HDAC9 DMXL2 CRTC3 SHROOM3 RAP1GAP GBF1 RAPH1 TRPM7 PPFIA2 DOCK9 RICTOR TSC1 STAU1 DST FAM13A BAIAP2L1 ASXL3 ZNF644 NAV2 AKAP13 MPHOSPH9 SSH2 PEAK1 HERC2 CDC25A PRRC2A | 7.16e-07 | 1319 | 145 | 27 | int:YWHAZ |
| Interaction | YWHAG interactions | FOXO3 MAGI1 NCOA6 CRTC3 SHROOM3 RAP1GAP GBF1 RAPH1 TRPM7 DOCK9 RICTOR TSC1 PRAG1 LRCH3 CDCA2 DST FAM13A BAIAP2L1 TET1 NAV2 AKAP13 MPHOSPH9 SSH2 PEAK1 CDC25A CNOT4 | 8.56e-07 | 1248 | 145 | 26 | int:YWHAG |
| Interaction | YWHAE interactions | FOXO3 HDAC9 CRTC3 SHROOM3 RAP1GAP GBF1 TRPM7 DOCK9 RICTOR TSC1 PRAG1 LRCH3 DST FAM13A BAIAP2L1 TET1 NAV2 PIMREG AKAP13 MPHOSPH9 SSH2 PEAK1 CDC25A PRRC2A CNOT4 | 3.25e-06 | 1256 | 145 | 25 | int:YWHAE |
| Interaction | YWHAQ interactions | FOXO3 NCOA6 CRTC3 SHROOM3 RAP1GAP GBF1 TRPM7 RICTOR TSC1 MED1 HNRNPF STAU1 DST FAM13A TET1 NAV2 NCOA1 AKAP13 MPHOSPH9 SSH2 PEAK1 CDC25A CNOT4 | 4.95e-06 | 1118 | 145 | 23 | int:YWHAQ |
| Interaction | LRRC31 interactions | 1.80e-05 | 205 | 145 | 9 | int:LRRC31 | |
| Interaction | HNF4A interactions | 3.11e-05 | 275 | 145 | 10 | int:HNF4A | |
| Interaction | NCAPH2 interactions | 3.11e-05 | 169 | 145 | 8 | int:NCAPH2 | |
| Interaction | MYO6 interactions | USP36 MAGI1 SHROOM3 RICTOR LRCH3 STAU1 YEATS2 EPS15L1 FAM13A LNPEP ITSN2 RPRD2 | 3.18e-05 | 398 | 145 | 12 | int:MYO6 |
| Interaction | TNRC6A interactions | 3.62e-05 | 280 | 145 | 10 | int:TNRC6A | |
| Interaction | YWHAB interactions | FOXO3 MAGI1 CRTC3 SHROOM3 RAP1GAP GBF1 TRPM7 DOCK9 RICTOR TSC1 DST FAM13A BAIAP2L1 NAV2 AKAP13 MPHOSPH9 SSH2 PEAK1 CDC25A CNOT4 | 3.99e-05 | 1014 | 145 | 20 | int:YWHAB |
| Interaction | DPM2 interactions | 4.28e-05 | 54 | 145 | 5 | int:DPM2 | |
| Interaction | GOLGA2 interactions | ZNF410 TRAF3IP2 NCOA6 GBF1 TSC1 CASZ1 STAU1 ZZZ3 ATXN7 TET1 ITSN2 FOXP1 PIMREG VPS13B AFF4 RAI1 | 7.83e-05 | 733 | 145 | 16 | int:GOLGA2 |
| Interaction | SMC5 interactions | USP36 NCOA6 BRIP1 MED1 ADNP NSRP1 HNRNPF STAU1 CDCA2 YEATS2 EPS15L1 ZZZ3 RFXANK ZNF644 RPRD2 PRRC2A PHIP AFF4 RAI1 | 1.04e-04 | 1000 | 145 | 19 | int:SMC5 |
| Interaction | PTPRS interactions | 1.22e-04 | 153 | 145 | 7 | int:PTPRS | |
| Interaction | GAGE2E interactions | 1.27e-04 | 36 | 145 | 4 | int:GAGE2E | |
| Interaction | TOP3B interactions | FOXO3 PITPNM2 NCOA6 SHROOM3 ABCA2 GBF1 TRIO GLRX3 DOCK9 IRAK1 MLLT10 PRAG1 CASZ1 STAU1 FAM20C EPS15L1 FAT1 DST NAV2 PCNX1 AKAP13 HERC2 PRRC2A RAI1 | 1.29e-04 | 1470 | 145 | 24 | int:TOP3B |
| Interaction | HDAC1 interactions | USP36 HDAC9 CASP8AP2 RAPH1 TRPM7 PPM1E IRAK1 KMT2E ADNP CASZ1 PALB2 LRCH3 STAU1 YEATS2 ZZZ3 DST TET1 AFF1 CRYBG3 RAI1 | 1.35e-04 | 1108 | 145 | 20 | int:HDAC1 |
| GeneFamily | Beta-gamma crystallin domain containing | 8.00e-05 | 3 | 94 | 2 | 1360 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.59e-04 | 4 | 94 | 2 | 1145 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.20e-04 | 206 | 94 | 6 | 682 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 9.40e-04 | 9 | 94 | 2 | 1280 | |
| GeneFamily | Forkhead boxes | 1.44e-03 | 43 | 94 | 3 | 508 | |
| GeneFamily | ATAC complex | 2.01e-03 | 13 | 94 | 2 | 1058 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.88e-03 | 18 | 94 | 2 | 91 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 4.32e-03 | 19 | 94 | 2 | 832 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 4.78e-03 | 20 | 94 | 2 | 548 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.92e-03 | 66 | 94 | 3 | 722 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FOXO3 DMXL2 GBF1 TRIO DOCK9 MED1 ADNP FCHSD2 FAT1 ZZZ3 DST ITSN2 NCOA1 AFF1 AKAP13 BICRAL MPHOSPH9 CRYBG3 PHIP CNOT4 VPS13B PLCE1 | 2.06e-09 | 856 | 145 | 22 | M4500 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | MAGI1 GBF1 RAPH1 TRIO EYA2 NCAPG2 MTPAP RRAGC CDCA2 FAT1 SPATS2L ZNF644 ITSN2 NAV2 NCOA1 FOXP1 MPHOSPH9 SSH2 HERC2 VPS13B FOXF1 PLCE1 | 3.96e-08 | 1009 | 145 | 22 | M157 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | FOXO3 DOCK9 ADNP FAT1 ZZZ3 DST AFF1 BICRAL PHIP CNOT4 VPS13B | 9.56e-07 | 300 | 145 | 11 | M8702 |
| Coexpression | GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN | 1.82e-06 | 200 | 145 | 9 | M7502 | |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 2.09e-06 | 38 | 145 | 5 | M39244 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 5.06e-06 | 289 | 145 | 10 | M2196 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | SLC12A6 HDAC9 SHROOM3 CCPG1 PPM1E PCDHB7 PGR CDKL5 EPS15L1 FAT1 TRANK1 CRYBG1 HSH2D FOXP1 CNOT4 RAI1 | 7.77e-06 | 786 | 145 | 16 | M10961 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.57e-05 | 199 | 145 | 8 | M5893 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 1.67e-05 | 145 | 145 | 7 | M1810 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | MAGI1 GBF1 RAPH1 EYA2 NCAPG2 RRAGC FAT1 SPATS2L ITSN2 NCOA1 MPHOSPH9 | 3.63e-05 | 441 | 145 | 11 | M172 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | USP36 FOXO3 NCOA6 TSC1 MTPAP RRAGC DST FAM13A ITSN2 NAV2 NCOA1 PCNX1 CNOT4 AFF4 PDZD2 | 5.33e-05 | 822 | 145 | 15 | M6782 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 5.96e-05 | 466 | 145 | 11 | M13522 | |
| Coexpression | GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN | 8.05e-05 | 128 | 145 | 6 | M410 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 1.05e-04 | 84 | 145 | 5 | M13008 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 1.11e-04 | 85 | 145 | 5 | M10575 | |
| Coexpression | GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP | 1.17e-04 | 197 | 145 | 7 | M8022 | |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN | 1.21e-04 | 198 | 145 | 7 | M5307 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN | 1.25e-04 | 199 | 145 | 7 | M7498 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | 1.25e-04 | 199 | 145 | 7 | M6964 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 1.29e-04 | 200 | 145 | 7 | M9463 | |
| Coexpression | GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN | 1.29e-04 | 200 | 145 | 7 | M2917 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.29e-04 | 200 | 145 | 7 | M8618 | |
| Coexpression | GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN | 1.29e-04 | 200 | 145 | 7 | M8480 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP | 1.29e-04 | 200 | 145 | 7 | M3830 | |
| Coexpression | GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN | 1.29e-04 | 200 | 145 | 7 | M7361 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_ADDNL_EXON_LVL_UP | 1.79e-04 | 94 | 145 | 5 | M40880 | |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 2.06e-04 | 152 | 145 | 6 | M39243 | |
| Coexpression | AMUNDSON_RESPONSE_TO_ARSENITE | 2.25e-04 | 219 | 145 | 7 | M262 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | CRTC3 BRIP1 TRIO PPM1E EYA2 NCAPG2 CDCA2 YEATS2 TNFSF11 TET1 ZC3HAV1L NAV2 AFF4 | 7.48e-06 | 423 | 146 | 13 | GSM476655_500 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | FOXO3 HDAC9 CRTC3 CCPG1 PPFIA2 EML6 C11orf24 CDKL5 EPS15L1 FAT1 SPATS2L FAM13A ASXL3 TET1 NCOA1 AFF1 PEAK1 PLEKHH2 PRRC2A CNOT4 VPS13B PLCE1 | 2.69e-05 | 1208 | 146 | 22 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | HDAC9 CCPG1 COL16A1 TRPM7 PPFIA2 KMT2E ITGB3BP CDKL5 FCHSD2 FAT1 SPATS2L DST ASXL3 ZNF644 TET1 ITSN2 NCOA1 SSH2 PEAK1 PLEKHH2 CNOT4 | 4.91e-05 | 1166 | 146 | 21 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.59e-08 | 193 | 146 | 9 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-08 | 198 | 146 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.07e-08 | 199 | 146 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-07 | 192 | 146 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-07 | 199 | 146 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-06 | 182 | 146 | 7 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.56e-06 | 184 | 146 | 7 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.56e-06 | 184 | 146 | 7 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.66e-06 | 185 | 146 | 7 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-06 | 185 | 146 | 7 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 187 | 146 | 7 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 187 | 146 | 7 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 187 | 146 | 7 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.96e-06 | 188 | 146 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-06 | 188 | 146 | 7 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 2.96e-06 | 188 | 146 | 7 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.17e-06 | 190 | 146 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.51e-06 | 193 | 146 | 7 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 194 | 146 | 7 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 194 | 146 | 7 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.64e-06 | 194 | 146 | 7 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.89e-06 | 196 | 146 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-cDC1|ICU-SEP / Disease, condition lineage and cell class | 4.02e-06 | 197 | 146 | 7 | e3174e90ea6136f1aa3a4a185b86458e35d51fd4 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.30e-06 | 199 | 146 | 7 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.44e-06 | 200 | 146 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 162 | 146 | 6 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 163 | 146 | 6 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-05 | 165 | 146 | 6 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.38e-05 | 174 | 146 | 6 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 2.38e-05 | 174 | 146 | 6 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.46e-05 | 175 | 146 | 6 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-05 | 178 | 146 | 6 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 179 | 146 | 6 | 479116ac65488c60104a053530830763ec1f95b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 179 | 146 | 6 | 1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 179 | 146 | 6 | 69a1b3b05c921de6343ffe6ad998aa2b804312a7 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 181 | 146 | 6 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 181 | 146 | 6 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.16e-05 | 183 | 146 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 184 | 146 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 184 | 146 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 184 | 146 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-05 | 185 | 146 | 6 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.35e-05 | 185 | 146 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 3.35e-05 | 185 | 146 | 6 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 186 | 146 | 6 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-05 | 186 | 146 | 6 | 74eb69a52090f9e2426a47e03a1c478ee0cfec18 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.56e-05 | 187 | 146 | 6 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-05 | 187 | 146 | 6 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 3.56e-05 | 187 | 146 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.67e-05 | 188 | 146 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 3.78e-05 | 189 | 146 | 6 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.78e-05 | 189 | 146 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.78e-05 | 189 | 146 | 6 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 189 | 146 | 6 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 189 | 146 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.78e-05 | 189 | 146 | 6 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 189 | 146 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-05 | 189 | 146 | 6 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 190 | 146 | 6 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 3.89e-05 | 190 | 146 | 6 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.89e-05 | 190 | 146 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 4.01e-05 | 191 | 146 | 6 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-05 | 191 | 146 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.01e-05 | 191 | 146 | 6 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | Severe-Treg|World / Disease group and Cell class | 4.01e-05 | 191 | 146 | 6 | 0a80b8c317e8da4d4722cfd13cdabc32b58021eb | |
| ToppCell | Mild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.01e-05 | 191 | 146 | 6 | 382686d62f7b8576c44bb9726a4e10dc26fd348e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.13e-05 | 192 | 146 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.13e-05 | 192 | 146 | 6 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 193 | 146 | 6 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 193 | 146 | 6 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 4.25e-05 | 193 | 146 | 6 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.37e-05 | 194 | 146 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.37e-05 | 194 | 146 | 6 | 3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.37e-05 | 194 | 146 | 6 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.37e-05 | 194 | 146 | 6 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.37e-05 | 194 | 146 | 6 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.37e-05 | 194 | 146 | 6 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.37e-05 | 194 | 146 | 6 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.37e-05 | 194 | 146 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-05 | 195 | 146 | 6 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.50e-05 | 195 | 146 | 6 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 4.50e-05 | 195 | 146 | 6 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-05 | 195 | 146 | 6 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.50e-05 | 195 | 146 | 6 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.50e-05 | 195 | 146 | 6 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Late_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.50e-05 | 195 | 146 | 6 | dfc5da514fb34a2c318a5c4c61f44049fa43960e | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.63e-05 | 196 | 146 | 6 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.63e-05 | 196 | 146 | 6 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 4.63e-05 | 196 | 146 | 6 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.63e-05 | 196 | 146 | 6 | 3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.63e-05 | 196 | 146 | 6 | 4f649e3bfd21f21682678828673843a7d51c4ff2 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.63e-05 | 196 | 146 | 6 | 799c290fb3dfacb666dd0dc3c43ec8a86b697ec7 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.63e-05 | 196 | 146 | 6 | 0c003a767c3b58605099dab64b9df0d8e5d8bc4b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 197 | 146 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | Control-Myeloid-proliferating_Myeloid_cells|Control / Disease group,lineage and cell class (2021.01.30) | 4.76e-05 | 197 | 146 | 6 | ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 197 | 146 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-05 | 197 | 146 | 6 | 76b61e60a757e58b465569538e632d6d9953e89a | |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 5.03e-05 | 199 | 146 | 6 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 5.18e-05 | 200 | 146 | 6 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.18e-05 | 200 | 146 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 4.65e-06 | 194 | 146 | 9 | 4662_DN | |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 5.49e-06 | 198 | 146 | 9 | 2242_DN | |
| Disease | household income | PITPNM2 GBF1 TRPM7 KMT2E UBOX5 SPATS2L PCNX1 FOXP1 CDC25A CNOT4 | 2.05e-06 | 304 | 140 | 10 | EFO_0009695 |
| Disease | asthma | USP36 PITPNM2 HDAC9 MAGI1 DMXL2 COL16A1 MUC16 EYA2 MED1 PRAG1 PLEKHG4B EPS15L1 ITSN2 FOXP1 ARHGAP27 | 3.05e-06 | 751 | 140 | 15 | MONDO_0004979 |
| Disease | Neurodevelopmental Disorders | 5.56e-06 | 93 | 140 | 6 | C1535926 | |
| Disease | cortical surface area measurement | FOXO3 PITPNM2 HDAC9 MAGI1 INTU SHROOM3 RAPH1 DOCK9 FAM13A TRIM8 NAV2 AFF1 FOXP1 MPHOSPH9 SSH2 ARHGAP27 PRRC2A CNOT4 PLCE1 PDZD2 | 5.85e-06 | 1345 | 140 | 20 | EFO_0010736 |
| Disease | vital capacity | FOXO3 HDAC9 NCOA6 SHROOM3 EYA2 MLLT10 MED1 KMT2E CASZ1 STAU1 DST FAM13A NCOA1 AFF1 FOXP1 RPRD2 PLCE1 PDZD2 | 2.36e-05 | 1236 | 140 | 18 | EFO_0004312 |
| Disease | pulse pressure measurement | USP36 FOXO3 HDAC9 SHROOM3 RAPH1 TRPM7 CASZ1 CEP164 TRANK1 FAM13A ATXN7 EEPD1 TET1 TRIM8 FOXP1 AKAP13 CDC25A HYDIN PLCE1 | 3.34e-05 | 1392 | 140 | 19 | EFO_0005763 |
| Disease | hepcidin:transferrin saturation ratio | 4.56e-05 | 15 | 140 | 3 | EFO_0007902 | |
| Disease | blood urea nitrogen measurement | SHROOM3 PPFIA2 DOCK9 OFCC1 CASZ1 HNRNPF CDKL5 AKAP13 HPS5 PLCE1 | 6.28e-05 | 452 | 140 | 10 | EFO_0004741 |
| Disease | cortical thickness | FOXO3 PITPNM2 HDAC9 MAGI1 INTU SHROOM3 DOCK9 MLLT10 STAU1 TNFSF11 NAV2 AFF1 FOXP1 SSH2 PLCE1 PDZD2 | 8.04e-05 | 1113 | 140 | 16 | EFO_0004840 |
| Disease | aspartate aminotransferase measurement | MAGI1 SHROOM3 BRIP1 TRPM7 EYA2 MLLT10 PRAG1 STAU1 FAM13A AKAP13 PRRC2A PHIP ALPK2 PLCE1 | 1.06e-04 | 904 | 140 | 14 | EFO_0004736 |
| Disease | serum gamma-glutamyl transferase measurement | FOXO3 BRIP1 TRPM7 IRAK1 OMG TRANK1 ZZZ3 NAV2 AFF1 AKAP13 PRRC2A CNOT4 ALPK2 PLCE1 | 1.19e-04 | 914 | 140 | 14 | EFO_0004532 |
| Disease | Metastatic melanoma | 1.28e-04 | 54 | 140 | 4 | C0278883 | |
| Disease | peak expiratory flow | 1.39e-04 | 498 | 140 | 10 | EFO_0009718 | |
| Disease | Malignant neoplasm of breast | NCOA6 RAP1GAP BRIP1 RAPH1 PPM1E PALB2 PGR STPG1 ZNF644 ITSN2 NCOA1 AFF1 HERC2 PRRC2A VPS13B | 1.86e-04 | 1074 | 140 | 15 | C0006142 |
| Disease | urinary albumin to creatinine ratio | 2.20e-04 | 179 | 140 | 6 | EFO_0007778 | |
| Disease | peritonitis (is_implicated_in) | 2.21e-04 | 5 | 140 | 2 | DOID:8283 (is_implicated_in) | |
| Disease | primary aldosteronism | 2.51e-04 | 26 | 140 | 3 | MONDO_0001422 | |
| Disease | neutrophil count | MAGI1 EML6 KMT2E CASZ1 RRAGC EPS15L1 BAIAP2L1 ATXN7 LNPEP ITSN2 NCOA1 AFF1 FOXP1 AKAP13 RPRD2 SSH2 HYDIN | 3.06e-04 | 1382 | 140 | 17 | EFO_0004833 |
| Disease | forced expiratory volume | HDAC9 NCOA6 DOCK9 MED1 CASZ1 SPATS2L DST AFF1 FOXP1 PLAU RPRD2 PHIP | 3.95e-04 | 789 | 140 | 12 | EFO_0004314 |
| Disease | migraine disorder, endometriosis | 4.10e-04 | 73 | 140 | 4 | EFO_0001065, MONDO_0005277 | |
| Disease | Obesity | 4.53e-04 | 205 | 140 | 6 | C0028754 | |
| Disease | multiple sclerosis | FOXO3 PITPNM2 EPS15L1 AFF1 FOXP1 AKAP13 PLAU MPHOSPH9 ARHGAP27 ALPK2 | 5.61e-04 | 594 | 140 | 10 | MONDO_0005301 |
| Disease | neuroimaging measurement | FOXO3 HDAC9 MAGI1 SHROOM3 DOCK9 MLLT10 OMG NAV2 AFF1 FOXP1 SSH2 ARHGAP27 RAI1 PLCE1 | 5.81e-04 | 1069 | 140 | 14 | EFO_0004346 |
| Disease | otosclerosis | 6.09e-04 | 81 | 140 | 4 | EFO_0004213 | |
| Disease | C-reactive protein measurement | TRAF3IP2 NCOA6 DMXL2 RAP1GAP RICTOR MLLT10 KCNB2 PRAG1 YEATS2 TNFSF11 TRANK1 ZNF644 EEPD1 FOXP1 AFF4 | 6.28e-04 | 1206 | 140 | 15 | EFO_0004458 |
| Disease | brain connectivity measurement | 6.71e-04 | 400 | 140 | 8 | EFO_0005210 | |
| Disease | osteoarthritis | 6.88e-04 | 222 | 140 | 6 | MONDO_0005178 | |
| Disease | eye color | 9.04e-04 | 90 | 140 | 4 | EFO_0003949 | |
| Disease | sphingolipid measurement | 9.08e-04 | 40 | 140 | 3 | EFO_0004622 | |
| Disease | serum alanine aminotransferase measurement | FOXO3 SHROOM3 BRIP1 GBF1 TRPM7 IRAK1 EYA2 PRAG1 ATP10D TRANK1 TET1 PLCE1 | 9.20e-04 | 869 | 140 | 12 | EFO_0004735 |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 9.77e-04 | 41 | 140 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 9.77e-04 | 41 | 140 | 3 | C0858252 | |
| Disease | abdominal aortic calcification measurement | 9.81e-04 | 10 | 140 | 2 | EFO_0010272 | |
| Disease | osteoarthritis, hip | 9.82e-04 | 92 | 140 | 4 | EFO_1000786 | |
| Disease | Endometrioma | 1.05e-03 | 161 | 140 | 5 | C0269102 | |
| Disease | Endometriosis | 1.05e-03 | 161 | 140 | 5 | C0014175 | |
| Disease | alkaline phosphatase measurement | GPLD1 RAP1GAP PRAG1 NGRN TNFSF11 TRANK1 BAIAP2L1 TRIM8 AKAP13 PLEKHH2 ALPK2 RAI1 PLCE1 | 1.12e-03 | 1015 | 140 | 13 | EFO_0004533 |
| Disease | reaction time measurement | 1.22e-03 | 658 | 140 | 10 | EFO_0008393 | |
| Disease | JT interval | 1.22e-03 | 248 | 140 | 6 | EFO_0007885 | |
| Disease | Pancreatic Neoplasm | 1.34e-03 | 100 | 140 | 4 | C0030297 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.36e-03 | 346 | 140 | 7 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | Clear Cell Meningioma | 1.43e-03 | 12 | 140 | 2 | C0431121 | |
| Disease | Intraventricular Meningioma | 1.43e-03 | 12 | 140 | 2 | C1334271 | |
| Disease | Benign Meningioma | 1.43e-03 | 12 | 140 | 2 | C0281784 | |
| Disease | Intraorbital Meningioma | 1.43e-03 | 12 | 140 | 2 | C1334261 | |
| Disease | Olfactory Groove Meningioma | 1.43e-03 | 12 | 140 | 2 | C1335107 | |
| Disease | Angioblastic Meningioma | 1.43e-03 | 12 | 140 | 2 | C1527197 | |
| Disease | Meningiomas, Multiple | 1.43e-03 | 12 | 140 | 2 | C0205834 | |
| Disease | Xanthomatous Meningioma | 1.43e-03 | 12 | 140 | 2 | C0457190 | |
| Disease | Angiomatous Meningioma | 1.43e-03 | 12 | 140 | 2 | C0334608 | |
| Disease | Psammomatous Meningioma | 1.43e-03 | 12 | 140 | 2 | C0334607 | |
| Disease | Fibrous Meningioma | 1.43e-03 | 12 | 140 | 2 | C0334606 | |
| Disease | Meningothelial meningioma | 1.43e-03 | 12 | 140 | 2 | C0334605 | |
| Disease | Hemangioblastic Meningioma | 1.43e-03 | 12 | 140 | 2 | C0334609 | |
| Disease | Transitional Meningioma | 1.43e-03 | 12 | 140 | 2 | C0334611 | |
| Disease | Hemangiopericytic Meningioma | 1.43e-03 | 12 | 140 | 2 | C0334610 | |
| Disease | Spinal Meningioma | 1.43e-03 | 12 | 140 | 2 | C0347515 | |
| Disease | Intracranial Meningioma | 1.43e-03 | 12 | 140 | 2 | C0349604 | |
| Disease | Papillary Meningioma | 1.43e-03 | 12 | 140 | 2 | C3163622 | |
| Disease | Malignant Meningioma | 1.43e-03 | 12 | 140 | 2 | C0259785 | |
| Disease | Sphenoid Wing Meningioma | 1.43e-03 | 12 | 140 | 2 | C1565951 | |
| Disease | Posterior Fossa Meningioma | 1.43e-03 | 12 | 140 | 2 | C1565950 | |
| Disease | Parasagittal Meningioma | 1.43e-03 | 12 | 140 | 2 | C0751304 | |
| Disease | Cerebral Convexity Meningioma | 1.43e-03 | 12 | 140 | 2 | C0751303 | |
| Disease | Microcystic meningioma | 1.43e-03 | 12 | 140 | 2 | C1384408 | |
| Disease | Secretory meningioma | 1.43e-03 | 12 | 140 | 2 | C1384406 | |
| Disease | Malignant neoplasm of pancreas | 1.44e-03 | 102 | 140 | 4 | C0346647 | |
| Disease | reticulocyte measurement | FOXO3 PITPNM2 RAP1GAP EML6 RICTOR EYA2 STAU1 FAT1 EEPD1 ZC3HAV1L FOXP1 AKAP13 PDZD2 | 1.56e-03 | 1053 | 140 | 13 | EFO_0010700 |
| Disease | neuroticism measurement, cognitive function measurement | 1.57e-03 | 566 | 140 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | coronary artery disease | HDAC9 NCOA6 SHROOM3 KCNH7 TRPM7 DOCK9 KCNB2 LNPEP AKAP13 RPRD2 PLEKHH2 CDC25A RAI1 PLCE1 | 1.67e-03 | 1194 | 140 | 14 | EFO_0001645 |
| Disease | Sjogren's Syndrome | 1.68e-03 | 13 | 140 | 2 | C1527336 | |
| Disease | Prader-Willi Syndrome | 1.68e-03 | 13 | 140 | 2 | C0032897 | |
| Disease | Sicca Syndrome | 1.68e-03 | 13 | 140 | 2 | C0086981 | |
| Disease | sleep duration | 1.76e-03 | 362 | 140 | 7 | EFO_0005271 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.82e-03 | 364 | 140 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | heart failure | 1.93e-03 | 185 | 140 | 5 | EFO_0003144 | |
| Disease | Fanconi anemia | 1.96e-03 | 14 | 140 | 2 | cv:C0015625 | |
| Disease | actinic keratosis | 1.96e-03 | 14 | 140 | 2 | EFO_0002496 | |
| Disease | asthma, body mass index | 1.96e-03 | 14 | 140 | 2 | EFO_0004340, MONDO_0004979 | |
| Disease | thyroid gland papillary carcinoma (is_marker_for) | 1.96e-03 | 14 | 140 | 2 | DOID:3969 (is_marker_for) | |
| Disease | diffuse large B-cell lymphoma | 1.96e-03 | 14 | 140 | 2 | EFO_0000403 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 1.96e-03 | 14 | 140 | 2 | C0677776 | |
| Disease | waist-hip ratio | FOXO3 DMXL2 ZNF407 C11orf24 EYA2 MLLT10 KCNB2 CDCA2 YEATS2 FAM13A TRIM8 PCNX1 PHIP PLCE1 | 2.13e-03 | 1226 | 140 | 14 | EFO_0004343 |
| Disease | Acute Cerebrovascular Accidents | 2.17e-03 | 54 | 140 | 3 | C0751956 | |
| Disease | Nasal Cavity Polyp | 2.29e-03 | 55 | 140 | 3 | EFO_1000391 | |
| Disease | body fat percentage | 2.36e-03 | 488 | 140 | 8 | EFO_0007800 | |
| Disease | longevity | 2.41e-03 | 284 | 140 | 6 | EFO_0004300 | |
| Disease | decreased susceptibility to hepatitis C infection | 2.57e-03 | 16 | 140 | 2 | EFO_0010101 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 2.57e-03 | 16 | 140 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.57e-03 | 16 | 140 | 2 | C0393706 | |
| Disease | white matter microstructure measurement | 2.67e-03 | 390 | 140 | 7 | EFO_0005674 | |
| Disease | mean arterial pressure | 2.70e-03 | 499 | 140 | 8 | EFO_0006340 | |
| Disease | creatinine measurement | FOXO3 INTU SHROOM3 BRIP1 PPFIA2 SLC6A19 MED1 CASZ1 CDKL5 ZZZ3 ATXN7 PLEKHH2 | 2.85e-03 | 995 | 140 | 12 | EFO_0004518 |
| Disease | respiratory symptom change measurement, response to placebo | 2.90e-03 | 17 | 140 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | Sjogren syndrome | 2.94e-03 | 60 | 140 | 3 | EFO_0000699 | |
| Disease | psoriasis vulgaris | 3.08e-03 | 61 | 140 | 3 | EFO_1001494 | |
| Disease | Cerebrovascular accident | 3.22e-03 | 62 | 140 | 3 | C0038454 | |
| Disease | red blood cell density measurement | SHROOM3 OFCC1 RICTOR CASZ1 DST FAM13A AFF1 FOXP1 AKAP13 SSH2 VPS13B | 3.24e-03 | 880 | 140 | 11 | EFO_0007978 |
| Disease | Bone marrow hypocellularity | 3.25e-03 | 18 | 140 | 2 | C1855710 | |
| Disease | Carcinoma of bladder | 3.25e-03 | 18 | 140 | 2 | C0699885 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SANASSLSSGQLKSP | 396 | Q9H2P0 | |
| SSLNSTGSLSPKHSL | 246 | Q9UBC2 | |
| SLQAGHPSSCNTSKA | 211 | P0C6C1 | |
| IHAPGTSKSSLSDSL | 1486 | Q68DQ2 | |
| TGVKPQNTAHSSTLL | 256 | Q8IZF6 | |
| ADSSPSKSNHSLSLQ | 161 | Q86TB3 | |
| ESNGHAVPANSSLLS | 941 | Q86V15 | |
| SQQEGLKLEHSSSLP | 31 | Q07092 | |
| SHGSDVSLSQILKPN | 1486 | Q12802 | |
| KGPFHILSSTSQTNK | 2741 | Q12802 | |
| KSLQGSHQAEPETSS | 266 | Q9ULG3 | |
| PHSSSIANLQTASKL | 956 | Q8TDJ6 | |
| LPNSAHSTSKSQSDL | 891 | Q9UKL3 | |
| SPSDKGQSKTHTINA | 1161 | Q96F81 | |
| AALTLLGSENPSKNH | 406 | Q7L9B9 | |
| STGQPLVTHSGSSKQ | 1616 | Q9C0F0 | |
| NKPSNHLAGSSFTLG | 511 | Q9P241 | |
| GHKPSSNRESSKQSA | 791 | Q9UHB7 | |
| TKSDDSFQSLHGSLP | 566 | Q7Z5J4 | |
| QRNSSIKSSSGAEHP | 976 | Q70E73 | |
| QEKPSNSESSLGAKH | 486 | Q9H0G5 | |
| SNTPDSGVSLLHKKS | 571 | Q9NZM3 | |
| HTASGTAPGTLKTLN | 3931 | Q14517 | |
| KSDIAPTAGHLSQTS | 3506 | Q8WXI7 | |
| KNIHISPNGATDSLT | 911 | P23467 | |
| AEPSSLLSLSASHNQ | 446 | Q96II8 | |
| ALHSLQSGSKQSTPK | 206 | Q96QZ7 | |
| SGNTSKLLPAGHSVS | 156 | Q9NPE2 | |
| ASSGSFLPSANEHLK | 116 | O76003 | |
| PSASGQDIQLSSKHT | 4606 | O95714 | |
| KEANSLASSGPHNLT | 31 | Q7Z5Y7 | |
| PFNHIKSSLLGSTSD | 306 | Q9NS40 | |
| DNKLSSSLAVSTHPD | 4756 | Q03001 | |
| DHTAGSSQSLSFPKL | 281 | Q9UPZ3 | |
| GLSTSASEEANKNPH | 481 | Q96RV3 | |
| KHSLPQLLDSSSASQ | 541 | O15018 | |
| SSSLTPGQISAHFQK | 511 | Q9H792 | |
| LSKSASEASPQSLPH | 391 | Q9H334 | |
| LSPGFSHLLSKNESS | 841 | Q99550 | |
| LISVSPHASGSLSNN | 1181 | Q8IZD2 | |
| KDSLNSSHPISSSVQ | 521 | Q9UIQ6 | |
| KESIGSLQNGTHTPS | 121 | Q9NVV4 | |
| QKGSGSPTHSLSQKS | 126 | Q9BSJ6 | |
| ASSIAQKAPDALSHT | 851 | Q9BZ72 | |
| QDSPSLIHGDIKSSN | 331 | P51617 | |
| PSKCSQDTGLSNLHA | 931 | O94988 | |
| TPQSNHLSLSKSNSV | 1271 | Q6R327 | |
| NSSDSTLSLGPFIHQ | 796 | O15265 | |
| ALSSQESKPEHQGLA | 316 | Q96JZ2 | |
| NSLSGKGTQLVPSSH | 421 | Q8IVE3 | |
| EQASHSLKSSFPGSL | 371 | Q9UNX9 | |
| LSAQEPSHKIGTSLS | 691 | Q8WY54 | |
| LNSKQHCLLESPTGS | 36 | Q9BX63 | |
| GDHSDSAKSVSSLNP | 861 | Q9ULD6 | |
| LNSEAPGSSNKSHEI | 146 | Q8IZS5 | |
| RPNSQSQHTKTGLSS | 686 | Q86YC2 | |
| PTTKSNHGGIASESL | 1931 | Q14686 | |
| AGHDNTKPDTSSSLL | 701 | P06401 | |
| PGSLQAEDSNASKTH | 326 | Q2TBC4 | |
| TFQINPTSGSLHLKA | 291 | Q9Y5E2 | |
| SPTSSEEQKHRNGLS | 46 | Q13352 | |
| QQLSGSQLHGKSDSP | 401 | Q9ULG6 | |
| IHGTPLSGKSANAVS | 2041 | Q4G0P3 | |
| NTSSSSPQHLSAQKL | 526 | Q92953 | |
| TIFPHTAGSNKTLLS | 346 | Q9UHR4 | |
| RSDQHGSKASSSLQP | 841 | Q6AI39 | |
| TPQKGSTLDNSLHKD | 1211 | Q9BZ29 | |
| SDPSSNLSSHSLEKL | 96 | Q8IXL6 | |
| TLNKTVLSSSLNNHP | 336 | Q6UUV7 | |
| PSSALDSQSGLHKGQ | 196 | Q9BZC7 | |
| SGSNHSTGENKSLPA | 446 | P20794 | |
| KNGNHTPSSSVGSSV | 846 | Q69YH5 | |
| QGQKPLASAHLTSAA | 1731 | Q92538 | |
| HPSKDLFISASNDGT | 1696 | Q6ZMW3 | |
| LFKSLHTNTNGNSEP | 791 | Q9Y4K1 | |
| PAVTSNGTLHSLNAD | 426 | O94868 | |
| ATKDTPTNGKNHSVS | 156 | Q9UKV0 | |
| GPTFKLTLHLQNTST | 496 | Q8NFJ9 | |
| GSTSKDLTNNNIPHL | 391 | O76039 | |
| SESSSGTNHSKRQPA | 741 | O76039 | |
| SLSQSTTGHLSLPQK | 946 | Q5VT52 | |
| PSAKSSDVLGSLNHE | 461 | Q9UHW9 | |
| SSSQNQHGSSKGKSP | 1281 | Q15648 | |
| LGSANSSQDSLHKAP | 811 | O75334 | |
| TLHQSLSLASSPKGT | 311 | P30304 | |
| PQAGSSLKHSTTLTN | 61 | O14593 | |
| IKTEDSLNHSPGQSG | 101 | O00167 | |
| VLKHSGPNSADSAND | 96 | P52597 | |
| ESSSLGSAKHQQQSP | 561 | O43524 | |
| AANPLSGSLSTHSLE | 296 | Q12946 | |
| AASKGSNHSSDFPQL | 506 | A2RUB1 | |
| TSHNALKILGNPASA | 781 | O15034 | |
| CSTGPLSHEQKLSQS | 416 | O94941 | |
| QKPGDHQGLVSTLST | 611 | Q695T7 | |
| TSASSLKALTHNGTP | 381 | Q9HB90 | |
| SDSKGSNELHQVPSN | 16 | P00749 | |
| LPLLNAHAATSGKQS | 371 | Q9NUQ6 | |
| NFSRKSSTHNKPSEG | 386 | Q9NUQ6 | |
| LSDKDGSSSHRQPTS | 411 | Q6ZQX7 | |
| ANSNALPSSSAGISK | 506 | Q9P212 | |
| GIQLPLTHSSSNKGD | 491 | Q86YW0 | |
| SSSDGKPLDSGLLHN | 601 | Q15788 | |
| ASLGIPHSSSSKENA | 291 | O94933 | |
| VPSHNSSTGLIASSK | 1446 | Q8IVL1 | |
| SIHKSSQDGDTPAQA | 451 | Q6ZUM4 | |
| AASAEPQSKNLDSGH | 1806 | P48634 | |
| GLSNKKPNTVSTSHS | 446 | P47736 | |
| HLSPAKSTGSIDQLS | 236 | Q8TF72 | |
| GTPCSTQISSLKEHN | 251 | P23515 | |
| LGSGHTPQSSSNSEK | 471 | Q8NFU7 | |
| TDSLNSSKSPHIGNS | 806 | P55197 | |
| LPRTQGSSKVHGSSN | 221 | P51825 | |
| QLSDSIASDPKSFHG | 396 | Q9UPV0 | |
| TGHDSDKSDQSLPNA | 161 | O43734 | |
| PTEHAQAKSNTASKG | 731 | Q86XI2 | |
| TPDKSHNSGVNISTL | 886 | Q14CN2 | |
| SPVTLTKGTSAAHLN | 61 | Q96F05 | |
| LQNSSSHTTTAKGPG | 436 | O95628 | |
| TTSAEQHLTGKKNSP | 791 | P63136 | |
| EIASSGQSPHIKSNL | 136 | Q7RTV5 | |
| GQSPHIKSNLLSGSL | 141 | Q7RTV5 | |
| TSTSTQKHSGRQLPG | 96 | A6NM28 | |
| SLPGSQRKTHSAASS | 511 | Q92574 | |
| LLTKTGAPHQDNAES | 66 | Q96G30 | |
| HSKALNTLSSPGQSS | 1551 | Q8WWQ0 | |
| SPTLTSHSKNSTGLA | 586 | Q96PX8 | |
| PTAETILKNNISSGH | 466 | O95793 | |
| SSSENIKSLSHSPGV | 1216 | Q76I76 | |
| KPQSDALLSSHGNAF | 901 | Q96PX9 | |
| HQSPVSNSVSLSKKG | 76 | Q5TH74 | |
| NHSNSSKEVPSSAVL | 61 | Q86VK4 | |
| GGSQLSQKHVSSPLA | 356 | P80108 | |
| PQGTASLRFSKSHSQ | 886 | A0A0J9YWL9 | |
| SSELAHSPTNSGKKL | 776 | Q86YV5 | |
| GTASPKLNLSHSETN | 841 | Q86YV5 | |
| GKHTLQPASNSSDAI | 151 | P43489 | |
| NATDIPSGSHKVSLS | 171 | O14788 | |
| NAFHTPKNTSVSLSG | 21 | Q96TA2 | |
| VNGPVSHSSLTKTSN | 116 | Q9H582 | |
| EFSKSGTHLPSNTKN | 91 | A2RUG3 | |
| FPSTTTKLLDGTHQQ | 1431 | Q7Z7G8 | |
| SSLHSDQSQGFQPSK | 161 | Q8N9F8 | |
| TTSAEQHLTGKKNSP | 796 | Q9WJR5 | |
| SGLHSLTVKPASGSQ | 511 | Q9C0G0 | |
| STAPGHTSQLKSQGS | 626 | O15050 | |
| HTSQLKSQGSFKSVP | 631 | O15050 | |
| TSSSLSPTKIGHLNS | 316 | Q9BZR9 | |
| LNIGHLPSAKESASQ | 461 | Q8IYH5 | |
| GKSSTGHSTNLPDLV | 431 | Q9H347 | |
| NQKLGSSSTSIPHLS | 1381 | Q96QT4 | |
| GPALSAALASSQKQH | 146 | Q96EF9 | |
| TSPKLLATATANGHG | 581 | Q9P275 | |
| SAISSNKTPHNSSIN | 741 | O75962 | |
| VSGLLKIHSSQSSPQ | 1031 | Q9ULM3 | |
| SSPSTEHSQGLEKQG | 256 | Q96H79 |